ION BIOSCIENCESBright ideas, Brilliant Solutions
C. David (Dave) Weaver, Ph.d.
President & Chief Science Officer
Dr. Weaver is President and Chief Science Officer of ION
Biosciences. Previously, he was the Lead Investigator of Drug Discovery at
Bristol-Myers Squibb (BMS). He was also part of the Senior Leadership Team, New
Leads Biology, Bristol-Myers Squibb Pharmaceutical Research Institute and
received the BMS Pharmaceutical Research Institute President’s Award.
Dr. Weaver currently holds the position of Associate
Professor of Pharmacology at the Vanderbilt University Medical School where he was
the former Director of the Vanderbilt Institute of Chemical Biology
High-throughput Screening Facility and former Director of Molecular
Pharmacology, Vanderbilt Program in Drug Discovery.
Dr. Weaver is the President and Founder, WaveFront
Biosciences. He is the principal
architect and driver of WaveFront’s Panoptic kinetic imaging plate reader platform.
Dr. Weaver has over 20 years of combined industrial and
academic drug discovery experience in the pharmaceutical industry and over 20
years of experience using kinetic imaging plate readers. He is also the Inventor
of the thallium flux assay used worldwide for potassium channel research and
CEO & Founder
Successful entrepreneur and financier, Mr. Conti has an
extensive history of recognizing opportunity, making strategic investments and bringing
numerous startups to fruition. Mr. Conti’s
global investment background includes real estate development, technology,
services and life science.
Akwasi Minta, Ph.d.
Dr. Akwasi Minta, a research organic chemist, has been
involved in design, synthesis and production of fluorescent ion indicators for
calcium, sodium, potassium, magnesium, zinc and chloride since 1983:
Specifically, Dr. Minta has worked with ion indicators as
applied to ion channels, biological and pharmaceutical research. Working with
the late Nobel Laureate Dr. Roger Tsien at the University of California,
Berkeley in the 1980s, Dr. Minta invented the first visible wavelength
indicators (Fluo-1, Fluo-2, Fluo-3, Rhod-1, Rhod-2), the first Sodium indicator
(SBFI), and the first Potassium indicator (PBFI). Dr. Minta proceeded to invent
the visible wavelength versions of the Sodium and Potassium indicators Asante
Natrium Green (ANG-1 and ANG-2), and Asante Potassium Green (APG-1, APG-2,
APG-3, and APG-4) respectively at Teflabs in Austin, Texas in the 2000s.
Dr. Minta's research at Ion Biosciences has produced his
previous research projects with publications including enzyme stereochemical
studies, synthesis of cardiotonic steroids, biosynthesis and synthesis of
Hasubanonine, and isolation and synthesis of natural products (Rubesamide). He
started research as an I.A.E.S.T.E (International Association for Exchange of
Students for Technical Experience) student (Ghana) at Nuclear Research Center,
Julich, West Germany.
Head of Production
Mr. Escamilla is head of production for ION. His background
includes design and production of synthetic fluorescent ion indicators for
cellular research and pharmaceutical screening (particularly, to probe
intracellular Ca, Na, and K ion levels).
Mr. Escalante is a production chemist at ION and all around good guy, has your back and knows how to make a serious iron skillet steak.
Ms. Pahnke is the Administrator coordinator for ION. In
addition to making sure all the behind the scenes functions run smoothly, she
is also an important point of contact for client services.
Mr. Huggans is the Director of Business Development for ION
Biosciences. His background includes President & CFO of TEF Labs, Inc. Austin Texas. TEF Labs focus was small
molecule design and Manufacturer of drug discovery tools for major
pharmaceutical companies worldwide. Mr. Huggans led the company to significant
growth in sales before personally negotiating the sale of the company’s IP to
publicly traded Invitrogen (NASDAQ: IVGN)
Mr. Huggans is the former Founder of a medical device
manufacturer, Tubemaster, Inc which designed
and manufactured radiographic and fluoroscopic imaging devices. As its
president and CFO, Mr. Huggans led the company to significant sales before
personally negotiating the sale of the company to publicly traded Richardson
Electronics (NASDAQ: RELL)